See also this year's filing and all EDGAR filings for this company.
PDF Report 0001386570_2026_Niagen_Bioscience_Inc.pdf
Logs
Graph
Absolute values for 0001386570, Niagen Bioscience Inc
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 1,815,000 |
| 1 | LiabilitiesCurrent | 19,919,000 |
| 2 | remainder_Liabilities | 8,139,000 |
| 3 | AssetsCurrent | 96,806,000 |
| 4 | AssetsNoncurrent | 2,617,000 |
| 5 | PropertyPlantAndEquipmentNet | 1,323,000 |
| 6 | Goodwill | 5,660,000 |
| 7 | remainder_Assets | 0 |
| 8 | GeneralAndAdministrativeExpense | 108,797,000 |
| 9 | ResearchAndDevelopmentExpense | 6,330,000 |
| 10 | remainder_Expenses | -1,173,000 |
| 11 | remainder_Revenues | 129,423,000 |
| 12 | remainder_NetIncome | 1,913,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 29,873,000 |
| 1 | Assets | 106,406,000 |
| 2 | Expenses | 113,954,000 |
| 3 | Revenues | 129,423,000 |
| 4 | StockholdersEquity | 76,533,000 |
| 5 | NetIncome | 17,382,000 |
| 6 | ComprehensiveNetIncome | 17,382,000 |
| 7 | BaseVar | 190,784,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.79 |
| 9 | EconomicCapitalRatio | 2.21 |
Edgar->Model Mapping
Feature Distribution
Change over Time
